Dr Reddys Laboratories RDY
NYSE RDY
$13.19 -0.07 (-0.57%)
As of: Oct 21, 2026 · 3:59 PM EDT

Dr Reddys Laboratories (RDY) Tax Provisions (2009 - 2026)

Updated

Dr Reddys Laboratories' Tax Provisions came in at $12.44 million for the quarter ended Jun 30, 2026, down 78.5% from $57.85 million a year earlier.

Analysis

Dr Reddys Laboratories (RDY) Tax Provisions (2009 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Dr Reddys Laboratories reported Tax Provisions of $96.57 million, down 58.1% year-over-year; for the year ended Mar 31, 2026, it was $132 million, down 42.4% from the prior year.

  • Tax Provisions carries a five-year compound annual growth rate of 1.1% (years ended Mar 2021 to Mar 2026).
  • Going back by year, Tax Provisions was $229 million in the year ended Mar 31, 2025 (+18.0%), $194 million in the year ended Mar 31, 2024 (+4.3%), $186 million in the year ended Mar 31, 2023 (+61.7%) and $115 million in the year ended Mar 31, 2022 (-8.0%).
  • The five-year range for quarterly Tax Provisions is -$2.34 million (the quarter ended Mar 31, 2026) to $68.68 million (the quarter ended Sep 30, 2024).
  • Year-over-year, Tax Provisions increased in three of the last seven quarters, with an average decline of 10.0%.
  • The fastest year-over-year change in Tax Provisions over five years came in the quarter ended Mar 31, 2023 (growth of 147.8%), and the weakest in the quarter ended Jun 30, 2026 (a decline of 78.5%).
  • Business Quant data shows RDY's Tax Provisions at -$2.34 million (quarter ended Mar 31, 2026), $39.67 million (quarter ended Dec 31, 2025) and $46.8 million (quarter ended Sep 30, 2025) in the three quarters before the quarter ended Jun 30, 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Taxes (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 2.15 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 1.21 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 662.00 Mn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 654.00 Mn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 1.01 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 291.00 Mn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 393.00 Mn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 242.00 Mn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -407.00 Mn
10 Dr Reddys Laboratories 10.97 Bn 10.34 Bn 396.53 Mn 12.44 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 12.44 Mn
Mar 31, 2026 -2.34 Mn
Dec 31, 2025 39.67 Mn
Sep 30, 2025 46.80 Mn
Jun 30, 2025 57.85 Mn
Mar 31, 2025 48.28 Mn
Dec 31, 2024 55.71 Mn
Sep 30, 2024 68.68 Mn
Jun 30, 2024 58.75 Mn
Mar 31, 2024 35.47 Mn
Dec 31, 2023 53.66 Mn
Sep 30, 2023 52.43 Mn
Jun 30, 2023 60.00 Mn
Mar 31, 2023 53.00 Mn
Dec 31, 2022 45.00 Mn
Sep 30, 2022 47.00 Mn
Jun 30, 2022 60.00 Mn
Mar 31, 2022 21.38 Mn
Dec 31, 2021 33.00 Mn
Sep 30, 2021 35.00 Mn
API Access

Dr Reddys Laboratories Tax Provisions API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=tax-provisions&ticker=RDY&period=max&api_key=YOUR_API_KEY